Aanchal is a seasoned investment analyst and financial journalist with a deep passion for the stock market. She specializes in fundamental analysis, focusing on uncovering the long-term value of stocks.
With a bachelor’s degree in finance, she combines academic knowledge with real-world insights to help investors make informed decisions. Her work is driven by a commitment to guiding readers toward building strong, resilient portfolios.
/A%20Palantir%20sign%20displayed%20on%20an%20office%20building%20by%20Poetra_RH%20via%20Shutterstock.jpg)
Palantir has been showing strong growth momentum, with Truist maintaining a bullish outlook for potential 2026 upside.
Geopolitical shifts may reshape Chevron’s outlook amid evolving energy dynamics. Should investors consider taking a position now?
/Raymond%20James%20Financial%2C%20Inc_%20location-by%20Jonathan%20Weiss%20via%20Shutterstock.jpg)
Raymond James Financial is expected to see modest near-term pressure, while longer-term outlook and analyst sentiment remain supportive.
/Transdigm%20Group%20Incorporated%20logo%20on%20mobile-by%20madamF%20via%20Shutterstock.jpg)
TransDigm Group is expected to report its Q1 2026 earnings soon, with slight near-term pressure anticipated, though analyst sentiment stays broadly positive.
Fox Corporation plans to unveil its Q2 2026 earnings shortly, with weaker performance anticipated, but sentiment remains broadly positive.
Atmos Energy is set to report its fiscal 2026 first-quarter earnings in the coming weeks, with analysts projecting moderate growth amid a cautious outlook.
/Idex%20Corporation%20logo%20and%20chart%20data-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Analysts maintain a cautiously optimistic stance on IDEX Corporation, expecting steady Q4 earnings despite lagging stock performance.
/Nike%2C%20Inc_%20logo%20by-%20Poetra_RH%20via%20Shutterstock.jpg)
Nike executives have increased personal stakes through insider buying, signaling confidence after a difficult year for the stock.
/Everest%20Group%20Ltd%20logo%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Analysts maintain an optimistic view on Everest Group’s outlook ahead of its earnings, even as the stock has shown mixed performance recently.
Analysts remain cautiously optimistic on Healthpeak despite sector headwinds and recent stock underperformance.
